PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.2128
https://www.valueinhealthjournal.com/article/S1098-3015(12)03842-9/fulltext
Title :
PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03842-9&doi=10.1016/j.jval.2012.08.2128
First page :
A425
Section Title :
Cancer
Open access? :
No
Section Order :
783